Denver Investment Advisors Trimmed By $10.20 Million Its Materion (MTRN) Position; Focused Wealth Management Has Lifted Teva Pharmaceutical Inds LTD (TEVA) Stake

February 17, 2018 - By Migdalia James

Focused Wealth Management Inc increased Teva Pharmaceutical Inds Ltd (TEVA) stake by 48.36% reported in 2017Q3 SEC filing. Focused Wealth Management Inc acquired 19,981 shares as Teva Pharmaceutical Inds Ltd (TEVA)’s stock declined 15.11%. The Focused Wealth Management Inc holds 61,297 shares with $1.08 million value, up from 41,316 last quarter. Teva Pharmaceutical Inds Ltd now has $21.25B valuation. The stock increased 0.43% or $0.09 during the last trading session, reaching $20.9. About 14.77M shares traded. Teva Pharmaceutical Industries Limited (NYSE:TEVA) has declined 41.70% since February 17, 2017 and is downtrending. It has underperformed by 58.40% the S&P500.

Denver Investment Advisors Llc decreased Materion Corp (MTRN) stake by 64.1% reported in 2017Q3 SEC filing. Denver Investment Advisors Llc sold 237,244 shares as Materion Corp (MTRN)’s stock declined 3.63%. The Denver Investment Advisors Llc holds 132,897 shares with $5.74M value, down from 370,141 last quarter. Materion Corp now has $1.00B valuation. The stock decreased 3.76% or $1.95 during the last trading session, reaching $49.95. About 135,794 shares traded or 13.47% up from the average. Materion Corporation (NYSE:MTRN) has risen 47.97% since February 17, 2017 and is uptrending. It has outperformed by 31.27% the S&P500.




Among 35 analysts covering Teva Pharma (NYSE:TEVA), 9 have Buy rating, 8 Sell and 18 Hold. Therefore 26% are positive. Teva Pharma had 146 analyst reports since July 21, 2015 according to SRatingsIntel. Bank of America upgraded the shares of TEVA in report on Tuesday, January 31 to “Buy” rating. The stock has “Neutral” rating by Credit Suisse on Wednesday, May 4. The stock has “Hold” rating by Cantor Fitzgerald on Thursday, June 22. On Friday, June 16 the stock rating was upgraded by Mizuho to “Buy”. The rating was downgraded by Jefferies on Wednesday, November 16 to “Hold”. Oppenheimer maintained Teva Pharmaceutical Industries Limited (NYSE:TEVA) on Friday, April 7 with “Buy” rating. The firm has “Hold” rating by Piper Jaffray given on Friday, July 14. The stock of Teva Pharmaceutical Industries Limited (NYSE:TEVA) has “Outperform” rating given on Wednesday, December 7 by Oppenheimer. The firm earned “Buy” rating on Friday, December 4 by Guggenheim. The firm has “Buy” rating given on Wednesday, November 16 by Maxim Group.

Focused Wealth Management Inc decreased Hewlett Packard Co Com (NYSE:HPQ) stake by 18,500 shares to 100 valued at $2,000 in 2017Q3. It also reduced Corning Inc (NYSE:GLW) stake by 11,544 shares and now owns 962 shares. Target Corp (NYSE:TGT) was reduced too.

Investors sentiment increased to 1.18 in 2017 Q3. Its up 0.31, from 0.87 in 2017Q2. It increased, as 6 investors sold MTRN shares while 44 reduced holdings. 22 funds opened positions while 37 raised stakes. 17.77 million shares or 1.02% less from 17.95 million shares in 2017Q2 were reported. Geode Capital Management Ltd Liability Corporation holds 167,883 shares or 0% of its portfolio. Millennium Mgmt Ltd Llc stated it has 0% in Materion Corporation (NYSE:MTRN). Barclays Public Llc owns 2,697 shares. California State Teachers Retirement accumulated 31,733 shares. First Midwest Retail Bank Division holds 0.04% or 7,886 shares. Morgan Stanley holds 0% or 131,204 shares. Schwab Charles Invest Mgmt owns 0.01% invested in Materion Corporation (NYSE:MTRN) for 190,108 shares. Menta Capital Lc invested in 0.18% or 28,087 shares. Dimensional Fund Advisors Lp holds 0.03% or 1.68M shares in its portfolio. Goldman Sachs Group Inc reported 0% of its portfolio in Materion Corporation (NYSE:MTRN). Jpmorgan Chase stated it has 0% of its portfolio in Materion Corporation (NYSE:MTRN). Robecosam Ag has invested 0.49% in Materion Corporation (NYSE:MTRN). Walthausen & Co Limited Liability Company has invested 0.99% of its portfolio in Materion Corporation (NYSE:MTRN). National Bank & Trust Of America Corp De reported 0% of its portfolio in Materion Corporation (NYSE:MTRN). Victory Cap reported 0% of its portfolio in Materion Corporation (NYSE:MTRN).

Since October 30, 2017, it had 0 insider buys, and 2 sales for $426,523 activity. $148,794 worth of Materion Corporation (NYSE:MTRN) was sold by Chemnitz Gregory R. on Monday, October 30. 5,267 Materion Corporation (NYSE:MTRN) shares with value of $277,729 were sold by SHULAR CRAIG S.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.